SMN2 and proximal spinal muscular atrophy: Our findings are consistent with Biogen’s phase 2 study NCT02386553 (NURTURE) which enrolled 25 patients with early-diagnosed SMA and 2 or 3 copies of the SMN2 gene shortly after birth [11].